Metformin Colonis

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Colonis (Metformin Hydrochloride)

Q: What is Metformin Colonis used for?

Metformin Colonis is a prescription‑only oral medication used to improve blood‑sugar control in adults with type 2 diabetes mellitus. It works as part of a comprehensive treatment plan that includes diet, exercise, and possibly other antidiabetic agents.

Q: How does Metformin Hydrochloride work?

Metformin Hydrochloride reduces the liver’s production of glucose and increases the sensitivity of muscle cells to insulin, which together lower circulating blood‑glucose levels. It does not stimulate insulin secretion, so it carries a low risk of causing hypoglycemia when used alone.

Q: What is the usual dose of Metformin Colonis?

The exact dose of Metformin Colonis is determined by the prescribing clinician based on the individual’s renal function, glycemic targets, and response to therapy. Typical starting doses are low and may be titrated upward, but the specific regimen should follow the prescriber’s instructions.

Q: Is Metformin Colonis safe during pregnancy or breastfeeding?

Metformin Colonis falls under an unknown pregnancy category in the EU. It may be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, and it should be prescribed by a specialist. Breastfeeding mothers should discuss risks with their healthcare provider.

Q: How do I order Metformin Colonis from GNH India?

To order Metformin Colonis, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Q: How does Metformin Colonis compare with other antidiabetic drugs?

Metformin Colonis belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors. It primarily lowers hepatic glucose output and improves insulin sensitivity, whereas other classes may increase insulin secretion or promote urinary glucose excretion. Metformin is often first‑line because of its efficacy, low cost, and low hypoglycemia risk.

Q: What are the storage requirements for Metformin Colonis?

Metformin Colonis should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain tablet integrity and potency.

Q: How is Metformin Colonis administered?

Metformin Colonis is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are determined by the prescribing clinician.

Q: What are the most serious risks to watch for while taking Metformin Colonis?

The most serious risk associated with Metformin Colonis is lactic acidosis, a rare but potentially fatal condition that may present with muscle pain, rapid breathing, abdominal discomfort, or unusual fatigue. Prompt medical attention is required if these symptoms occur, especially in patients with renal or hepatic impairment.

Q: Who should not use Metformin Colonis?

Metformin Colonis should be avoided in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those undergoing certain radiographic procedures using iodinated contrast without appropriate discontinuation.

Metformin Hydrochloride, the active ingredient in Metformin Colonis, is a Biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults by improving insulin sensitivity and reducing hepatic glucose production.

GNH India supplies Metformin Colonis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution.

Manufacturer / TM Owner

Colonis Pharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Colonis is indicated for the management of type 2 diabetes mellitus, the primary disease state targeted by this biguanide.

Type 2 diabetes mellitus (fasting hyperglycemia): lowers fasting plasma glucose and HbA1c.
Type 2 diabetes mellitus (postprandial hyperglycemia): reduces post‑meal glucose excursions.
Type 2 diabetes mellitus (combination therapy): enhances overall glycemic control when added to other antidiabetic agents.

How It Works

Metformin Hydrochloride inhibits mitochondrial respiratory‑chain complex I, decreasing hepatic gluconeogenesis. This reduction in hepatic glucose output, together with increased peripheral glucose uptake and enhanced insulin receptor signaling, lowers circulating blood glucose. The drug does not stimulate insulin secretion, thereby minimizing hypoglycemia risk when used alone.

Side Effects

Metformin Colonis may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects

Nausea: mild to moderate upset stomach.
Diarrhea: loose stools, often transient.
Abdominal discomfort: cramping or pain.
Metallic taste: transient alteration in taste perception.
Loss of appetite: reduced desire to eat.
Flatulence: increased intestinal gas.

Serious or Rare Side Effects

Lactic acidosis: rare but potentially fatal metabolic disturbance.
Severe hypoglycemia: uncommon when used alone, may occur with other agents.
Hepatic dysfunction: elevated liver enzymes.
Pancreatitis: inflammation of the pancreas.
Severe skin reactions: such as Stevens‑Johnson syndrome.
Anemia: reduction in red blood cell count.

Precautions & Warnings

When prescribing Metformin Colonis, clinicians should consider several safety measures.

Renal function assessment: avoid use in patients with eGFR <30 mL/min/1.73 m².
Hepatic impairment: use with caution in moderate liver disease.
Cardiovascular status: monitor for heart failure as risk of lactic acidosis increases.
Concomitant contrast imaging: discontinue before iodinated contrast procedures.
Vitamin B12 monitoring: long‑term therapy may reduce B12 levels; check periodically.
Store at ambient temperature: keep below 25 °C in original container, protect from moisture.

Avoid Interactions

Metformin Colonis can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

Iodinated contrast agents: can precipitate acute renal failure and lactic acidosis.
Cimetidine: may increase metformin plasma concentrations.
Nucleoside reverse transcriptase inhibitors (e.g., didanosine): raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

Diuretics (thiazides, loop): may impair renal clearance of metformin.
ACE inhibitors/ARBs: can affect renal function, requiring dose adjustment.
Beta‑blockers: may mask hypoglycemia symptoms when combined with other agents.
Oral corticosteroids: may increase blood glucose, necessitating dose titration.

Frequently Asked Questions

Metformin Colonis is a prescription‑only oral medication used to improve blood‑sugar control in adults with type 2 diabetes mellitus. It works as part of a comprehensive treatment plan that includes diet, exercise, and possibly other antidiabetic agents.

Metformin Hydrochloride reduces the liver’s production of glucose and increases the sensitivity of muscle cells to insulin, which together lower circulating blood‑glucose levels. It does not stimulate insulin secretion, so it carries a low risk of causing hypoglycemia when used alone.

The exact dose of Metformin Colonis is determined by the prescribing clinician based on the individual’s renal function, glycemic targets, and response to therapy. Typical starting doses are low and may be titrated upward, but the specific regimen should follow the prescriber’s instructions.

Metformin Colonis falls under an unknown pregnancy category in the EU. It may be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, and it should be prescribed by a specialist. Breastfeeding mothers should discuss risks with their healthcare provider.

To order Metformin Colonis, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Metformin Colonis belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors. It primarily lowers hepatic glucose output and improves insulin sensitivity, whereas other classes may increase insulin secretion or promote urinary glucose excretion. Metformin is often first‑line because of its efficacy, low cost, and low hypoglycemia risk.

Metformin Colonis should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain tablet integrity and potency.

Metformin Colonis is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are determined by the prescribing clinician.

The most serious risk associated with Metformin Colonis is lactic acidosis, a rare but potentially fatal condition that may present with muscle pain, rapid breathing, abdominal discomfort, or unusual fatigue. Prompt medical attention is required if these symptoms occur, especially in patients with renal or hepatic impairment.

Metformin Colonis should be avoided in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those undergoing certain radiographic procedures using iodinated contrast without appropriate discontinuation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.